ClinicalTrials.gg
RecruitingNCT06946537INSIGHTUpdated Oct 2, 2026

Nutritional Status and Patient Characteristics Upon Length of Stay, Clinical Outcome, and Survival in Older Hospitalized Patients

An observational study in Geriatric, Malnutrition and Length of Stay, sponsored by Bispebjerg Hospital. Recruiting at 1 site in Denmark. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-10-02.

Sponsored by Bispebjerg Hospital · Observational

How we know

From the registry’s dates

  • Started May 2025; still recruiting 1 year 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,500
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 42 studies in Malnutrition with a site in Denmark — 8 open to participants now, 10 under way, none of them phase 3. Malnutrition · Denmark.

Started
2025
with 3 others
Observational
7 of 42
2 open now
Registered
39th of 42
by date
Lead sponsor
7 of 42
Bispebjerg Hospital

Among the 42 studies in Malnutrition with a site in Denmark, this one is one of 4 that started in 2025, is one of 7 observational ones, and was the 39th registered.

Malnutrition

1,278 studies on the registry are indexed under Malnutrition; 231 are open to participants now.

Browse Malnutrition studies →

Open to participants now

8 of the 42 studies in Malnutrition with a site in Denmark are open now. Recruiting first, the newest first:

2 more — sign in →

All 8 open studies →

A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →

Who these studies take

Of the 150 Malnutrition studies recruiting now, 84 (56%) set no upper age limit and 44 (29%) stop at 75 or younger; 40 take children under 18; 30 take healthy volunteers.

This study: 65 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 42 studies in Malnutrition with a site in Denmark, or all of them as a file.
02

Study summary

Disease-related malnutrition (DRM) describes undernutrition or imbalances in energy, protein, or other nutrient-needs, caused by a concomitant disease. Nutritional status plays a vital role in the fate of hospitalized patients, and DRM is associated with loss of function and decreased survival.

DRM is a common condition in patients with acute illnesses, approximately 30% among medical inpatients are malnourished when admitteed to the hospital, and rise higher among the older or critically ill. Physiologically malnutrition is associated with a) poorer tissue healing and restitution after severe disease, b) suppressed immune function and resistance towards infections, c) poorer metabolic defense towards critical disease, d) delayed and poorer progress of chronic diseases. In addition, inadequate nutrition is coupled to a prolonged hospital stay, resulting in more readmissions, and overall higher mortality in hospital patients. Yet, nutritional status of patients upon hospital admittance is seldom systematically assessed and the consequences of DRM in older acutely admitted patients still needs to be understood.

This project will provide a detailed description of nutritional, physiolgical, and biochemical status of 1500 acutely admitted patients. In relation, the study will investigate the relation between patient characteristics and disease progression. The obtained data will also be coupled to patient registers to investigate the link between length of hospital stay, readmissions and acute contact, and mortality.

03

Conditions studied

  • Geriatric
  • Malnutrition
  • Length of Stay

Browse trials for

Keywords

  • Geriatric
  • Disease-related malnutrition
  • Physiology
  • Acute illness
  • Deep phenotyping
  • Nutritional status
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients acutely admitted at Bispebjerg Hospital

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Acutely admitted adults aged 65 years and above.
  • Be able to comply with the study information, as assessed by the research personnel.
  • Be able to understand Danish.

Exclusion criteria

Exclusion Criteria:

  • \<24 hours admission
  • Terminal illness in end stage of life
  • Patients with temporary civil person registration number (CPR)
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,500 participants (estimated)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • The INSIGHT cohort

    A geriatric cohort (age ≥ 65) established to investigate the coupling of phenotypical characteristics to nutritional and physiological status. The study intent to explore whether Disease-Related Malnutrition provides predictive value for patient prognosis based on specific phenotypic characteristics and establish different physiological stratifications to improve the identification of acutely admitted patients.

    Other: Exposures and measurements

Interventions

  • OtherExposures and measurements

    Anthropometry, Body composition (BIA), Nutritional screening (GLIM, SNAQ, NIS, NRS-2002), Functional tests, Seisomocardiography, Muscle strength, Blood tests, Fecal swabs, Indirect calorimetry Orientation-Memory-Concentration (OMC), Sarcopenia, Frailty (Clinical Frailty Scale), Comobidity, Polypharmacy, Portrait photo.

06

What researchers measure

Primary outcomes

  1. Length of Hospital Stay

    Time (in hours) hospitalized from arrival to discharge

    Time frame: From date of hospital admission untill discharge, assessed up to 2 months

Secondary outcomes

  1. Readmission

    Time to readmission from discharge

    Time frame: Time to readmission 30 days from discharge

  2. Acute contact

    Time to acute contact from discharge

    Time frame: Time to acute contact 30 days from discharge

  3. Mortality

    Time to mortality from index admission

    Time frame: Time to mortality 90 days from index admission

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — The following will be available: Study Protocol and Statistical Analysis Plan (SAP).

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2025 (actual). Primary completion is estimated for Apr 2027, 23 months after the start.

Of 175 non-industry observational studies under Malnutrition, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 41. This study's planned 23 months is close to that.

Counting every sponsor, half of 187 studies reached it within 21 months; a quarter within 11 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 25, 2025
First posted
Apr 27, 2025
StartActual
May 12, 2025
Primary completionEst.
Apr 2027
CompletionEst.
Nov 2028
Last update
Oct 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: index terms and verification date
1 update, last Oct 2, 2026
Show all 1 update
  1. Oct 2, 2026
    Minor edits only
    + 2 other changes: index terms and verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06946537
Responsible party
Charlotte Suetta (Professor, Bispebjerg Hospital) — Principal investigator
First posted
Apr 27, 2025
Start date
May 12, 2025
Primary completion
Apr 2027 (estimated)
Completion
Nov 2028 (estimated)
Last update
Oct 2, 2026

Study contacts

Jacob B Jespersen, MSc
Contact
jacob.baekgaard.jespersen@regionh.dk
+4522321355

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion